Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benno Weigmann

Showing results (21-30 of 83) with videos related to

Pageof 9
Sort By:
International Journal of Pharmaceutics|January 8, 2019
Advances in orally-delivered pH-sensitive nanocarrier systems; an optimistic approach for the treatment of inflammatory bowel diseaseMahira Zeeshan, Hussain Ali, Salman Khan, et al.
International Journal of Cancer|June 19, 2013
Nuclear factor of activated T cells - a transcription factor family as critical regulator in lung and colon cancerCarolin Daniel, Katharina Gerlach, Martin Väth, et al.
International Journal of Molecular Sciences|November 26, 2022
Surface Design Options in Polymer- and Lipid-Based siRNA Nanoparticles Using AntibodiesMichael Gabel, Annkathrin Knauss, Dagmar Fischer, et al.
The Journal of Allergy and Clinical Immunology|July 7, 2015
Activated glycoprotein A repetitions predominant (GARP)-expressing regulatory T cells inhibit allergen-induced intestinal inflammation in humanized miceMelanie Eschborn, Benno Weigmann, Sonja Reissig, et al.
The Journal of Experimental Medicine|August 22, 2012
Smad3 binding to the foxp3 enhancer is dispensable for the development of regulatory T cells with the exception of the gutSusan M Schlenner, Benno Weigmann, Qingguo Ruan, et al.
The Journal of Allergy and Clinical Immunology|May 21, 2021
Depletion of CD56<sup>+</sup>CD3<sup>+</sup> invariant natural killer T cells prevents allergen-induced inflammation in humanized miceRobert Ose, Benno Weigmann, Detlef Schuppan, et al.
Nature Protocols|October 20, 2007
Isolation and subsequent analysis of murine lamina propria mononuclear cells from colonic tissueBenno Weigmann, Ingrid Tubbe, Daniel Seidel, et al.
Expert Opinion on Drug Delivery|February 21, 2022
Small but powerful: will nanoparticles be the future state-of-the-art therapy for IBD?Kristina Lechner, Mahira Zeeshan, Maxi Noack, et al.
The Journal of Investigative Dermatology|May 22, 2016
Epicutaneous and Oral Low-Zone Tolerance Protects from Colitis in MiceTalkea Schmidt, Nadine Lorenz, Verena Raker, et al.
Asian Journal of Pharmaceutical Sciences|August 17, 2023
Dual pH and microbial-sensitive galactosylated polymeric nanocargoes for multi-level targeting to combat ulcerative colitisMahira Zeeshan, Qurat Ul Ain, Benno Weigmann, et al.
Pageof 9

Showing results (21-30 of 83) with videos related to

Sort By:
Pageof 9
International Journal of Pharmaceutics|January 8, 2019
Advances in orally-delivered pH-sensitive nanocarrier systems; an optimistic approach for the treatment of inflammatory bowel diseaseMahira Zeeshan, Hussain Ali, Salman Khan, et al.
International Journal of Cancer|June 19, 2013
Nuclear factor of activated T cells - a transcription factor family as critical regulator in lung and colon cancerCarolin Daniel, Katharina Gerlach, Martin Väth, et al.
International Journal of Molecular Sciences|November 26, 2022
Surface Design Options in Polymer- and Lipid-Based siRNA Nanoparticles Using AntibodiesMichael Gabel, Annkathrin Knauss, Dagmar Fischer, et al.
The Journal of Allergy and Clinical Immunology|July 7, 2015
Activated glycoprotein A repetitions predominant (GARP)-expressing regulatory T cells inhibit allergen-induced intestinal inflammation in humanized miceMelanie Eschborn, Benno Weigmann, Sonja Reissig, et al.
The Journal of Experimental Medicine|August 22, 2012
Smad3 binding to the foxp3 enhancer is dispensable for the development of regulatory T cells with the exception of the gutSusan M Schlenner, Benno Weigmann, Qingguo Ruan, et al.
The Journal of Allergy and Clinical Immunology|May 21, 2021
Depletion of CD56<sup>+</sup>CD3<sup>+</sup> invariant natural killer T cells prevents allergen-induced inflammation in humanized miceRobert Ose, Benno Weigmann, Detlef Schuppan, et al.
Nature Protocols|October 20, 2007
Isolation and subsequent analysis of murine lamina propria mononuclear cells from colonic tissueBenno Weigmann, Ingrid Tubbe, Daniel Seidel, et al.
Expert Opinion on Drug Delivery|February 21, 2022
Small but powerful: will nanoparticles be the future state-of-the-art therapy for IBD?Kristina Lechner, Mahira Zeeshan, Maxi Noack, et al.
The Journal of Investigative Dermatology|May 22, 2016
Epicutaneous and Oral Low-Zone Tolerance Protects from Colitis in MiceTalkea Schmidt, Nadine Lorenz, Verena Raker, et al.
Asian Journal of Pharmaceutical Sciences|August 17, 2023
Dual pH and microbial-sensitive galactosylated polymeric nanocargoes for multi-level targeting to combat ulcerative colitisMahira Zeeshan, Qurat Ul Ain, Benno Weigmann, et al.
Pageof 9